Article
NOD2 and bacterial recognition as therapeutic targets for Crohn's disease.
Expert opinion on therapeutic targets - 1 Dec 2017
de Bruyn Magali, Vermeire Séverine
Abstract excerpt
INTRODUCTION: Crohn's disease (CD) is a chronic, disabling disease of the gastrointestinal tract that mostly affects young adults. Despite extensive research, the pathogenesis of CD is still not completely understood. It is thought that an abnormal mucosal immune response is elicited towards the luminal microbiota in genetically predisposed persons. Genome-wide association studies and meta-analysis have greatly...
Topics
Join the communities discussing this publication.
